글로벌 허혈성 뇌졸증 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 허혈성 뇌졸증 시장

허혈성 뇌졸중 시장은 2022-2029년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 7.07%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

허혈성 뇌졸중은 혈전으로 인해 뇌에 혈액을 공급하는 혈관이 막혀 신경 기능이 상실되는 경우 발생합니다. 반신마비, 사지마비, 단안마비의 갑작스러운 발병, 단안 시력 상실, 복시, 시야 결손, 반신 감각 결손, 구음 장애, 얼굴 처짐, 현기증, 운동 실조, 안진, 실어증, 의식 상태 저하 등은 모두 허혈성 뇌졸중의 징후입니다.

The rise in the prevalence of ischemic cerebral stroke will act as major driver that will results in the expansion of market’s growth. Another significant factor influencing the growth rate of ischemic cerebral stroke market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, rising initiatives by public and private organisations to spread awareness and growing government funding are the factors that will expand the ischemic cerebral stroke market. Other factors such as increase in the demand for effective therapies and rising geriatric population will positively impact the ischemic cerebral stroke market’s growth rate. Additionally, high disposable income and surge in the adoption rate of sedentary lifestyle will result in the expansion of ischemic cerebral stroke market. Also, growing incidences high cholesterol, diabetes, high blood pressure and clotting disorders, alcohol abuse and high smoking consumption will cushion the growth of ischemic cerebral stroke market

Moreover, the rise in the investment level for research and development activities and emerging new markets will provide beneficial opportunities for the ischemic cerebral stroke market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate ischemic cerebral stroke market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of ischemic cerebral stroke market. Additionally, complications involved with ischemic cerebral stroke will hinder the ischemic cerebral stroke market growth. Less awareness and multiple patent expiries of branded drugs will further challenge the market in the forecast period mentioned above.

This ischemic cerebral stroke market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Ischemic cerebral stroke market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Ischemic Cerebral Stroke Market Scope and Market Size

The ischemic cerebral stroke market is segmented on the basis of drug class, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drug class, the ischemic cerebral stroke market is segmented into calcium channel blockers, thrombolytics and others.
• On the basis of treatment, the ischemic cerebral stroke market is segmented into medication, surgery and others.
• On the basis of diagnosis, the ischemic cerebral stroke market is segmented into computed tomography (CT) angiography and CT scan, carotid duplex scanning, magnetic resonance imaging (MRI), digital subtraction angiography and others.
• On the basis of symptoms, the ischemic cerebral stroke market is segmented into sudden onset of hemiparesis, quadriparesis, and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia, loss of consciousness and others.
• On the basis of dosage, the ischemic cerebral stroke market is segmented into injection, tablets and others.
• On the basis of route of administration, the ischemic cerebral stroke market is segmented into oral, intravenous and others.
• On the basis of end-users, the ischemic cerebral stroke market is segmented into clinic, hospital and others.

The ischemic cerebral stroke market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Ischemic Cerebral Stroke Market Country Level Analysis

Ischemic cerebral stroke market is analyzed and market size information is provided by the country, drug class, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the ischemic cerebral stroke market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the ischemic cerebral stroke market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

환자 역학 분석

허혈성 뇌졸중 시장은 또한 환자 분석, 예후 및 치료에 대한 자세한 시장 분석을 제공합니다. 유병률, 발생률, 사망률, 준수율은 보고서에서 사용할 수 있는 일부 데이터 변수입니다. 시장 성장에 대한 역학의 직접 또는 간접 영향 분석을 분석하여 성장 기간 동안 시장을 예측하기 위한 보다 견고하고 코호트 다변량 통계 모델을 만듭니다.

경쟁 환경 및 글로벌 허혈성 뇌졸증 시장 점유율 분석

허혈성 뇌졸중 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 포함됩니다. 위에 제공된 데이터 포인트는 허혈성 뇌졸중 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

허혈성 뇌졸중 시장의 주요 기업으로는 F. Hoffmann-La Roche Ltd., PLx Pharma Inc., Johnson & Johnson Private Limited, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Sanofi, Apotex Inc., Amneal Pharmaceuticals LLC., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Mylan NV, Novartis AG, Bausch Health Companies Inc., Zydus Cadila, Glenmark Pharmaceuticals Limited, Sofgen Pharmaceuticals, Arbor Pharmaceuticals, AbbVie Inc. 등이 있습니다.

SKU-24769